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Introduction {#sec1}
============

The signaling network of nutrient-sensing, insulin/insulin growth factor signaling (IIS) and Target of Rapamycin (TOR) influences healthy lifespan in diverse eukaryotic organisms, including mammals ([@bib1]). Specific alleles of IIS genes ([@bib32], [@bib38], [@bib52], [@bib59]) and transcriptional variation of genes encoding components of the TOR pathway ([@bib37]) are associated with survival to advanced ages in humans. Reduced network activity can induce a broad-spectrum resistance to age-related loss of function and disease in animal models ([@bib14], [@bib28], [@bib48], [@bib53]), making it an attractive target for pharmacological intervention to improve human health during aging ([@bib16]). Indeed, attenuation of TOR signaling by rapamycin extends lifespan in diverse species, including mice ([@bib9], [@bib21]), as does inhibition of the Ras-Erk branch of IIS by the drug trametinib in *Drosophila* ([@bib50]).

In addition to its effect on aging, the IIS/TOR network regulates growth, metabolism, stress responses, and fecundity, potentially resulting in undesired side effects of reduction of network activity. For example, at some doses, rapamycin is a strong immunosuppressant ([@bib16]) and can also impair wound healing ([@bib51]), while trametinib is a Mek1/2 inhibitor with anti-proliferative properties ([@bib63]). Therefore, we need to uncover molecular and mechanistic outputs of nutrient-sensing networks in order to triage apart the positive effects of intervention from the negative effects inherent in manipulating upstream network nodes. In particular, we need to determine the tissue-specific effect of signaling activity in lifespan extension and the physiological processes underlying it.

Recent studies identified the intestinal tissue as pivotal in aging ([@bib3], [@bib8], [@bib45]), and they have mainly focused on hyperplastic intestinal pathology resulting from age-dependent intestinal stem cell (ISC) over-proliferation as a major determinant of lifespan ([@bib8]). However, while stem cell maintenance is no doubt important for intestinal homeostasis, hyperplasia may not occur early enough to influence the early tipping point between young and old metabolic states. Therefore, other aspects of intestinal physiology that determine lifespan still remain to be elucidated.

Outputs of the IIS/TOR signaling network are mediated by several transcription factors (TFs). For instance, in *C. elegans* and *Drosophila*, the single Fork Head Box O (FoxO) TF is required for extended lifespan from lowered IIS ([@bib19], [@bib24], [@bib35], [@bib49], [@bib59]). In *C. elegans* the heat shock TF HSF-1 ([@bib23]) and the Nrf-like xenobiotic response factor SKN-1 ([@bib55]) are also required. In *Drosophila*, lowered IIS increases lifespan through both the canonical IIS pathway and its FOXO effector, and through the Ras-Erk-ETS branch and its transcriptional repressor effector *anterior open* (AOP) ([@bib50]). In *Drosophila*, at least one other TF is also likely to play a role, because the TF-binding sites upstream of genes regulated by lowered IIS imply the involvement of a FKH box family member other than dFOXO ([@bib2]).

The Fork Head box (FOX) family of TFs shares a conserved DNA-binding domain, whose sequence assigns them to subclasses from FoxA to FoxS ([@bib30]). The *Drosophila* FoxA homolog FKH is the founding member and namesake, and it plays an essential role in embryonic development ([@bib58]). FKH also regulates larval cell size in a rapamycin- and TOR-dependent manner ([@bib12]). Mammalian FoxAs regulate glucose metabolism in the liver, pancreas, and adipose tissue ([@bib18]), and liver-specific knockout of FoxA2 results in a premature aging phenotype and increased mTOR activity in mouse ([@bib10]).

We have investigated the role of *Drosophila* FKH in the IIS-and-TOR-signaling network and, in particular, its key role in intestinal aging. We find that FKH interacts with and is phosphorylated by both dAKT and dTOR, placing it as a central transcriptional regulator. Concordantly, we demonstrate an essential requirement for FKH for both IIS- and rapamycin-induced longevity, as well as IIS-induced starvation resistance, a phenotype previously shown to be dFOXO independent ([@bib49]). We locate the longevity effects of FKH to intestinal tissue and specifically to differentiated intestinal cells. We establish that the anti-aging effects of rapamycin and intestinal IIS downregulation both require, and can be recapitulated by, FKH induction in the gut. Gut barrier function loss over aging is improved by intestinal FKH upregulation, while ISC proliferation remains unaffected. Transcriptomic analysis of adult guts revealed FKH-dependent upregulation of nutrient transporters upon reduced IIS. Consistent with this finding, we demonstrate an FKH-dependent increase in nutrient absorption upon reduced IIS and gut-specific FKH overexpression, suggesting improved gut absorption as a possible underlying longevity mechanism. Concordantly, starvation resistance declines over age, but it is rescued by intestinal FKH upregulation in young and old flies. Additionally, we show upregulation of related nutrient transporters in *irs1* knockout mouse intestine, suggesting evolutionary conservation of this mechanism. Overall, our results demonstrate FKH-dependent functional consequences of reduced IIS for intestinal absorption, and they imply that FoxA is an evolutionarily conserved regulator of lifespan and gut function, pointing to new directions for therapeutic intervention into aging-related loss of function.

Results {#sec2}
=======

FKH Overexpression Results in Increased Longevity {#sec2.1}
-------------------------------------------------

FOXO overexpression can increase longevity in both worms and flies ([@bib1]), and overexpression of the FoxA homolog *pha-4* can also do so in *C. elegans* ([@bib36]). To determine whether *Drosophila* FKH plays a similar role, we assessed the effect of ubiquitous, adult-onset FKH overexpression on lifespan.

We used the inducible daughterless Gene Switch (*daGS*) driver to produce a graded increase in FKH expression, by varying the concentration of the activating drug RU486. Strong FKH induction led to short-lived flies ([Figure 1](#fig1){ref-type="fig"}A), whereas weaker induction resulted in lifespan extension ([Figure 1](#fig1){ref-type="fig"}A; 10 μM median survival + 9%, p = 6.94 × 10^−6^). Intermediate induction at 50 and 100 μM RU486 resulted in early life mortality, and upregulation at 200 μM RU486 resulted in significantly short-lived flies. To more precisely define the range of induction that maximized lifespan, we used 10 and 20 μM RU486, and we found significant extension at both concentrations ([Figure 1](#fig1){ref-type="fig"}B; 10 μM RU486 median survival +9%, p = 0.003 and 20 μM median survival +14%, p = 6.33 × 10^−6^). Moderate, ubiquitous, adult-specific upregulation of FKH expression is thus sufficient to extend *Drosophila* lifespan in a dose-dependent manner.Figure 1Ubiquitous Overexpression of FKH Extends Lifespan(A and B) Survival curves of female flies expressing the *UAS-fkh* transgene under the control of the *daGS* driver at different RU486 concentrations. Ubiquitous overexpression of FKH extended lifespan (A) at 10 and 50 μM RU486 (p = 6.94 × 10^−6^ and p = 0.017, respectively) and (B) at 10 and 20 μM RU486 (p = 0.003 and p = 6.33 × 10^−6^, respectively). See also [Table S1](#mmc1){ref-type="supplementary-material"}.

Weakening immune response and hence lowered defense against infection contribute to decline of health during aging ([@bib64]). FKH was recently proposed to act as a regulator of innate immune response in *Drosophila* larvae ([@bib56]). As an indicator of healthspan, we assessed the survival upon systemic infection with *Erwinia carotovora carotovora15* (*Ecc15)*, a Gram-negative bacterium that has been used as a model of natural infection in *Drosophila* larvae and adults ([@bib4]). Systemic *Ecc15* infection at 1 week of age resulted in lower mortality than did infection at 7 weeks of age (p = 0.00052), suggesting a decline in immune response over age. Overexpression of FKH led to increased survival at both ages ([Figure S1](#mmc1){ref-type="supplementary-material"}; p = 0.00014 and p = 0.0001 for young and old cohorts, respectively). Hence, FKH activity results in more efficient immunity and attenuates age-related decline in immune function.

IIS Induces Phosphorylation and a Marked Decrease in Nuclear Localization of FKH {#sec2.2}
--------------------------------------------------------------------------------

IIS activity results in phosphorylation and nuclear exclusion of dFOXO by *Drosophila* AKT (dAKT), and, thereby, it controls the expression of dFOXO target genes. We first determined whether IIS activity has similar effects on FKH, by searching for the appearance of a slow-migrating FKH protein band on polyacrylamide gels ([@bib41]). *Drosophila* S2 cells were transfected with an HA-tagged FKH construct, serum starved, and then stimulated with insulin, and protein extracts were run on polyacrylamide gels containing PhosTag ([@bib29]). Immunoblotting of unstimulated cell extracts revealed a band just above 64 kDa, while extracts from insulin-stimulated cells contained a slower migrating band of around 98 kDa, already apparent at 15 min post-insulin stimulation, with the highest intensity at 30 min ([Figure 2](#fig2){ref-type="fig"}A). Phosphatase treatment resulted in a single band at 64 kDa for all time points ([Figure 2](#fig2){ref-type="fig"}B), indicating that phosphorylation caused the appearance of the slow-migrating FKH band.Figure 2Activation of IIS Results in FKH Phosphorylation, and FKH Interacts with AKT and TOR In Vitro(A) S2 cells were transfected with HA-tagged FKH construct and stimulated with insulin for 5, 15, 20, and 30 min. A band above 64 kDa was detected in extracts pre-insulin stimulation. A slower migrating band at ∼98 kDa was present in extracts isolated post-insulin stimulation.(B) Following phosphatase treatment of the same extracts, a single band corresponding to non-phosphorylated FKH-HA was present (lower panel).(C) S2 cells were visualized for FKH-HA protein (green), Actin (red), and nuclei stained by DAPI (blue) pre-and post-insulin treatment for 20 min. Quantification of nuclear FKH revealed a significant difference between two conditions (Fisher's exact test, p \< 0.0001).(D) Ex vivo insulin-stimulated guts were stained for endogenous FKH (green) and DAPI-stained nuclei (blue) and in two different sections of midgut: R2 (left panel) and R4 (right panel). Initially strong nuclear FKH staining was markedly decreased in both R2 (t test, p = 0.045; n = 4) and R4 (t test, p = 0.0014; n = 4) upon insulin stimulation. Error bars represent SD.(E) S2 cells were transiently transfected with the indicated cDNAs in expression vectors. Anti-HA immunoprecipitates were prepared, and cell lysates were analyzed by immunoblotting with either anti-HA or anti-FLAG antibodies.(F and G) Recombinant FKH-HIS was incubated in an in vitro kinase reaction with active recombinant (F) Akt1 or (G) mTORC1 radiolabelled \[γ-33P\]ATP. Reactions lacking either the substrate or the kinase served as negative controls. Proteins were separated by SDS-PAGE and phosphorylated proteins were visualized by autoradiography. In reactions with mTORC1, the incorporation of \[γ-33P\]ATP was also observed at a higher molecular weight (∼160 kDa), which probably reflected the previously reported phosphorylation of raptor by mTOR ([@bib57]).(H) S2 cells were transiently transfected with the dTOR-FLAG vector. Anti-FLAG immunoprecipitates were prepared, and cell lysates were analyzed by immunoblotting with either anti-FKH or anti-FLAG antibodies.

We next assessed if the subcellular localization of FKH was changed by IIS, using transiently overexpressed FKH-HA protein and immunofluorescence of S2 cells pre- and post-stimulation with insulin. Around 20% of unstimulated transfected cells showed strong nuclear staining of HA-tagged FKH protein, which was lost upon stimulation with insulin ([Figure 2](#fig2){ref-type="fig"}C). To determine whether insulin affected localization of endogenous FKH in adult tissue, guts were isolated from 5-day-old flies and stimulated with insulin ex vivo for 20 min. The *Drosophila* gut is regionalized in morphology and function ([@bib11]), and we measured FKH localization in two regions of the midgut, R2 and R4. In both, insulin stimulation led to reduced nuclear FKH staining ([Figure 2](#fig2){ref-type="fig"}D).

IIS activity thus results in phosphorylation of FKH in cell culture and a substantial decrease in nuclear localization of FKH in both cell culture and gut ex vivo, demonstrating IIS regulation of FKH function.

FKH Interacts with AKT and TOR In Vitro {#sec2.3}
---------------------------------------

We next determined where FKH is integrated into the IIS/TOR network. Since mammalian FoxA2 interacts with mAKT1 in vitro ([@bib60]) and FKH genetically interacts with dTOR in *Drosophila* larval fat body ([@bib12]), we investigated AKT and TOR kinases as candidates for a potential interaction with FKH.

*Drosophila* S2 cells were transiently transfected with HA-tagged FKH and/or a FLAG-tagged dAKT. Following 15 min of insulin stimulation, FKH-HA protein was co-immunoprecipitated as part of a complex with FLAG-tagged dAKT ([Figure 2](#fig2){ref-type="fig"}E). Since FKH could physically interact with dAKT, we next assessed whether AKT could phosphorylate FKH. Recombinant, His-tagged FKH was expressed in *E.coli* and purified. An in vitro kinase assay was carried out using mammalian recombinant active mAKT, and phosphorylation of FKH was assessed by the incorporation of \[γ-33P\]ATP. FKH-His was phosphorylated upon incubation with active mAKT ([Figure 2](#fig2){ref-type="fig"}F).

To assess whether FKH interacted physically with dTOR, S2 cells were transfected with FLAG-tagged dTOR, which was co-immunoprecipitated with endogenous FKH protein ([Figure 2](#fig2){ref-type="fig"}H). An in vitro kinase assay with recombinant active mTORC1 and purified FKH-His resulted in the phosphorylation of FKH ([Figure 2](#fig2){ref-type="fig"}G).

FKH can interact physically with both AKT and TOR and can be phosphorylated by them, and it could thus integrate signals from these two kinases.

FKH Functions Downstream of IIS to Determine Lifespan {#sec2.4}
-----------------------------------------------------

In *Drosophila,* the reduction of IIS in adult flies results in a complex array of phenotypes, including resistance to starvation, oxidative stress and xenobiotics, reduced fecundity, and increased longevity ([@bib49]).

To determine the contribution of FKH function to longevity, we knocked down *fkh* using RNAi in wild-type flies and flies with a dominant-negative version of the single-fly IIS receptor *InR*^*DN*^. Assessment of transcript levels by qPCR showed that ubiquitous RNAi against *fkh* resulted in an ∼65% reduction in *fkh* expression ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Ubiquitous, adult-specific expression of *InR*^*DN*^ with the inducible *daGS* driver resulted in a significant lifespan extension in flies with co-overexpression of *GFP RNAi*, to control for possible titration of GAL4 ([Figure 3](#fig3){ref-type="fig"}A; median survival +14%, p = 4.45 × 10^−10^). However, RNAi against *fkh* both substantially reduced the lifespan of wild-type flies and blocked the extension of lifespan by *InR*^*DN*^ ([Figure 3](#fig3){ref-type="fig"}B; p = 0.08). Cox Proportional Hazard (CPH) analysis established that the response to the presence of the activating drug RU486 in *daGS;UAS-InR*^*DN*^ flies was significantly different in the presence and absence of *fkh* RNAi ([Table S3](#mmc1){ref-type="supplementary-material"}; p = 0.0432). To confirm that IIS was biochemically active upon FKH RNAi, we assessed expression levels of the dFOXO target *4EBP*, and we found a significant increase upon reduced IIS on both wild-type and FKH knockdown background ([Figure S2](#mmc1){ref-type="supplementary-material"}E; t test, p \< 0.05).Figure 3FKH Is Required for Reduced IIS- and Rapamycin-Induced Longevity(A) *daGS;UAS-InR*^*DN*^*\> UAS-GFP RNAi* females showed increased lifespan in the presence of RU486 (p = 4.45 × 10^−10^). Survival of *daGS \> UAS-GFP RNAi* females was not different between --RU486 and +RU468 conditions (p = 0.508). See also [Table S2](#mmc1){ref-type="supplementary-material"}A.(B) *daGS \> UAS-fkh RNAi* and *daGS;UAS-InR*^*DN*^*\> UAS-fkh RNAi* flies showed significantly decreased lifespan in the presence of RU486 (p = 1.97 × 10^−54^ and p = 2.59 × 10^−63^, respectively). No significant difference in survival was detected between *daGS \> UAS-fkh RNAi* +RU486 and *daGS;UAS-InR*^*DN*^*\> UAS-fkh RNAi* +RU486 flies (p = 0.08). See also [Table S2](#mmc1){ref-type="supplementary-material"}B.(C) *chico* mutation increased lifespan of *daGS\>UAS-GFP* RNAi females in the absence (p = 6.28 × 10^−7^) and in the presence (p = 2.71 × 10^−6^) of RU486. See also [Table S2](#mmc1){ref-type="supplementary-material"}C.(D) *chico* mutation extended lifespan in *daGS \> UAS-fkh RNAi* female flies in the absence of RU486 (p = 3.86 × 10^−8^), but not in its presence (p = 0.61). See also [Table S2](#mmc1){ref-type="supplementary-material"}D.(E) Rapamycin extended the lifespan of *daGS \> UAS-fkh RNAi* female flies in the absence of RU486 (p = 2.37 × 10^−8^), but not in its presence (p = 0.81). See also [Table S2](#mmc1){ref-type="supplementary-material"}E.

We examined the role of FKH in the extension of lifespan by a second IIS mutant, heterozygous *chico*^*1*^, which has lost a single copy of the insulin receptor substrate and is long-lived ([@bib14]). *chico*^*1*^ heterozygotes were long-lived with control GFP RNAi ([Figure 3](#fig3){ref-type="fig"}C; median survival +8%, p = 2.71 × 10^−6^), but they lost this lifespan extension with RNAi against *fkh* ([Figure 3](#fig3){ref-type="fig"}D; p = 0.61), confirmed by CPH analysis ([Table S3](#mmc1){ref-type="supplementary-material"}; p = 0.00452). To confirm the specificity of the effect of *fkh* RNAi, we used a second *fkh* RNAi line ([@bib12]) (referred to as *UAS*-*fkh RNAi 2)* that also prevented lifespan extension upon overexpression of *UAS-InR*^*DN*^ and heterozygous *chico*^*1*^ mutation ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2D).

These data show that FKH function is essential for mediating the lifespan-extending effects of reduced IIS in *Drosophila*.

FKH Mediates Lifespan Extension by Rapamycin, but Not by Dietary Restriction {#sec2.5}
----------------------------------------------------------------------------

TOR is a conserved serine/threonine kinase that is present as two distinct protein complexes, TORC1 and TORC2. TORC1 activity can be directly inhibited by rapamycin ([@bib15], [@bib26]), which can also extend lifespan in yeast ([@bib40]), *C. elegans* ([@bib47]), *Drosophila* ([@bib9]), and mice ([@bib21]). Our results showed biochemical interaction between FKH and TOR, and we therefore examined whether FKH is required for rapamycin-induced longevity.

Treatment of control flies with 100 μM rapamycin resulted in significant lifespan extension ([Figure 3](#fig3){ref-type="fig"}E; median survival +6.5%, p = 2.37 × 10^−8^), which was abolished by ubiquitous, adult-specific RNAi against *fkh* ([Figure 3](#fig3){ref-type="fig"}E; p = 0.81), confirmed by CPH analysis ([Table S3](#mmc1){ref-type="supplementary-material"}; p = 5.5 × 10^−4^). The biochemical effect of rapamycin upon FKH RNAi was confirmed by assessing phosphorylation levels of S6K, which were decreased on both wild-type and FKH knockdown backgrounds following rapamycin treatment ([Figure S2](#mmc1){ref-type="supplementary-material"}F). FKH thus functions downstream of TOR to mediate the extension of lifespan by rapamycin.

TOR kinase can play a role in the extension of lifespan by dietary restriction (DR) ([@bib20]), and the *C. elegans* homolog of *fkh* is required for DR-induced longevity ([@bib36]). We subjected flies overexpressing *fkh* RNAi and uninduced controls to DR, and we found that DR promoted longevity in both ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B; at 0.5× versus 1× yeast concentration, for +RU486 condition median survival +18%, p = 1.02 × 10^−10^, and for −RU486 condition median survival +3%, p = 0.03, respectively). Importantly, since ubiquitous RNAi again *fkh* shortened lifespan, the extension of lifespan in these flies by DR indicates that the failure to extend in response to reduced IIS and rapamycin was specific to these interventions.

Together these results indicate that FKH is required for rapamycin-induced, but not DR-induced, longevity.

FKH Is Required for IIS-Induced Starvation Resistance {#sec2.6}
-----------------------------------------------------

In addition to its effect on lifespan, lowered IIS is associated with resistance to starvation, oxidative stress, and xenobiotics. We therefore determined whether these types of stress resistance require FKH function.

Flies were subjected to oxidative stress by supplementing their food with paraquat, a superoxide generator. Flies expressing *InR*^*DN*^ were resistant to paraquat ([Figure 4](#fig4){ref-type="fig"}A; p = 0.00058). Ubiquitous RNAi against GFP or *fkh* did not affect the resistance of either wild-type ([Figure S4](#mmc1){ref-type="supplementary-material"}A) or *InR*^*DN*^-expressing flies ([Figure 4](#fig4){ref-type="fig"}A; [Table S3](#mmc1){ref-type="supplementary-material"}). Resistance to xenobiotic treatment was tested by supplementing fly food with dichlorodiphenyltrichloroethane (DDT). Ubiquitous RNAi against GFP or *fkh* did not affect resistance of wild-type flies to DDT ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Reduction of IIS by *InR*^*DN*^ expression resulted in a small, but significant, increase in resistance ([Figure 4](#fig4){ref-type="fig"}B; p = 0.0013), but flies lacking *fkh* function showed even greater resistance to DDT upon reduction of IIS ([Figure 4](#fig4){ref-type="fig"}B; p = 0.00028). FKH function is thus not required for reduced IIS to induce resistance to oxidative stress or xenobiotic treatment, and indeed somehow it interferes with the latter.Figure 4Functions of FKH during Lowered IIS-Induced Oxidative Stress, Xenobiotics, Starvation Resistance, and Reduced Fecundity(A and B) The (A) paraquat and (B) DDT resistance of *daGS;UAS-InR*^*DN*^*\> UAS-GFP RNAi* and *daGS;UAS-InR*^*DN*^*\> UAS-fkh RNAi* females was significantly increased in the presence of RU486 (p = 0.00058 and p = 1.46 × 10^−7^; p = 0.0013 and p = 3.58 × 10^−14^, respectively). See also [Table S4](#mmc1){ref-type="supplementary-material"}, A and B.(C) Starvation resistance of *daGS;UAS-InR*^*DN*^*\> UAS-GFP RNAi* females was significantly increased in the presence of RU486 (p = 3.66 × 10^−5^), but resistance to starvation was not different for *daGS;UAS-InR*^*DN*^*\> UAS-fkh RNAi* in the presence of RU486 (p = 0.085). See also [Table S4](#mmc1){ref-type="supplementary-material"}C.(D) Cumulative number of eggs per female over 3 weeks following RU486 induction. Data are presented as the mean number of eggs laid per female over a 24-hr period each week ± SEM; t test revealed a significant difference between +RU486 and −RU486 conditions for *daGS;UAS-InR*^*DN*^*\> UAS-GFP RNAi* (p = 2.04 × 10^−7^), *daGS;UAS-InR*^*DN*^*\> UAS-fkh RNAi* (p = 0.0037), and *daGS \> UAS-fkh RNAi* (p = 1.63 × 10^−5^).

Resistance to starvation was assessed by exposing flies only to agar. Ubiquitous RNAi against GFP or *fkh* did not affect the response to starvation ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Flies with reduced IIS were resistant to starvation ([Figure 4](#fig4){ref-type="fig"}C; p = 3.66 × 10^−5^). Knocking down *fkh* resulted in a loss of starvation resistance in flies expressing *InR*^*DN*^ ([Figure 4](#fig4){ref-type="fig"}C; p = 0.085), with CPH revealing a significant difference between these conditions ([Table S3](#mmc1){ref-type="supplementary-material"}; p = 4 × 10^−5^). Resistance to starvation upon the downregulation of IIS thus requires FKH function.

IIS mutant females often have a fecundity deficit ([@bib49]), and we assessed the role of FKH in this trait. RNAi against GFP did not affect egg-laying ([Figure 4](#fig4){ref-type="fig"}D; p = 0.47). Reduction of IIS resulted in a substantial decrease in fecundity ([Figure 4](#fig4){ref-type="fig"}D; p = 2.04 × 10^−7^), as did *fkh* RNAi alone ([Figure 4](#fig4){ref-type="fig"}D; p = 1.63 × 10^−5^). Knocking down *fkh* in flies with lowered IIS neither restored nor exacerbated their fecundity deficit. These results suggest that FKH is not required for the reduced fecundity observed upon the downregulation of IIS. The decrease in fecundity observed upon reduced IIS and *fkh* RNAi alone was not additive, and, therefore, it was likely to be occurring through independent mechanisms.

Upregulation of FKH in the Gut Extends Lifespan and Improves Gut Barrier Function {#sec2.7}
---------------------------------------------------------------------------------

Many targets of TFs are cell type specific ([@bib22]). Indeed, both dFOXO ([@bib3], [@bib54]) and AOP ([@bib3]) have distinct targets in different tissues. Interestingly, *dfoxo* or *aop* activity in the abdominal fat body and adult midgut results in longevity, whereas their upregulation in the gut alone does not ([@bib3]). A possible reason for the requirement of several distinct TFs for IIS-mediated lifespan is, thus, the tissue specificity of their action. We therefore investigated possible tissue specificity of FKH action to affect lifespan. A plethora of studies in both *C. elegans* ([@bib33], [@bib55]) and *Drosophila* ([@bib3], [@bib8], [@bib44], [@bib50]) has pointed to adipose and/or intestinal tissue as key mediators of the effects of reduced IIS on lifespan, and we therefore investigated the role of FKH in these two tissues.

Overexpression of FKH in the adult gut using the inducible TiGS driver, which expresses throughout the gut including differentiated cells ([@bib3]), significantly increased lifespan ([Figure 5](#fig5){ref-type="fig"}A; median survival +6%, p = 0.00015), but its overexpression simultaneously in abdominal fat body and gut with *S*~*1*~*106* driver did not ([Figure S5](#mmc1){ref-type="supplementary-material"}A; p = 0.093). Furthermore, FKH overexpression restricted solely to ISCs and enteroblasts (EBs) with *GS5961* driver ([@bib8]) did not affect longevity ([Figure S5](#mmc1){ref-type="supplementary-material"}B; p = 0.21). RU486 feeding had no effect on the lifespan of control flies with the UAS transgene or driver alone ([Figures S5](#mmc1){ref-type="supplementary-material"}D--S5H).Figure 5FKH Upregulation in the Gut Extends Lifespan, and Intestinal FKH Function Mediates Longevity Effects of Rapamycin and Reduced IIS(A) Adult gut-specific overexpression of *UAS*-*fkh* under the control of TiGS driver extended lifespan (p = 0.00015). See also [Table S5](#mmc1){ref-type="supplementary-material"}A.(B) Quantification of the proportion of "Smurf" flies with leaky guts at 10 weeks of age in *TiGS\>UAS-fkh* flies revealed a significant reduction in Smurf numbers in the +RU486 condition (two-tailed Fisher's exact test, p \< 0.0001; n \> 200 flies per condition).(C) Rapamycin extended the lifespan of *TiGS \> UAS-fkh RNAi* females in the absence of RU486 (p = 1.79 × 10^−12^), but not in its presence (p = 0.57). See also [Table S5](#mmc1){ref-type="supplementary-material"}B.(D) *TiGS \< UAS-InR*^*DN*^ females were long-lived in the presence of RU486 (p = 0.014). See also [Table S5](#mmc1){ref-type="supplementary-material"}C.(E) Survival of *TiGS \> UAS-fkh RNAi* females was not affected by RU468 (p = 0.077). The reduction of IIS upon overexpression of *UAS*-*fkh RNAi* led to significantly short-lived flies (p = 8.97 × 10^−7^). See also [Table S5](#mmc1){ref-type="supplementary-material"}, D and E.

These results show that at least part of the lifespan-extending effect of FKH activity occurs in the gut, in contrast to dFOXO. However, FKH upregulation solely in the progenitor cells (ISCs and EBs) is not sufficient to extend lifespan, suggesting involvement of other gut cell types.

To determine how FKH acts in the gut to extend lifespan, we examined the gut barrier function by feeding aged flies with a blue dye that does not normally leak into the body cavity ([@bib45]), and we scored the proportion of "Smurf" flies, in which leakage occurred. FKH overexpression resulted in a significant decrease in the number of Smurfs at 10 week of age ([Figure 5](#fig5){ref-type="fig"}B; Fisher's exact test, p \< 0.0001), indicating stronger gut barrier function.

ISC proliferation increases with age, eventually leading to intestinal dysplasia ([@bib7], [@bib13]). To determine whether FKH function affects age-related proliferation of ISCs, we assessed the number of PH3-positive cells in the gut, but we did not find any difference at either young or old age between FKH-overexpressing and control flies ([Figure S5](#mmc1){ref-type="supplementary-material"}C; t test, p = 0.42 and p = 0.51).

These results suggest that FKH overexpression in the gut maintains barrier function during aging, but it does not affect ISC proliferation.

FKH Function in the Gut Mediates Rapamycin-Induced Longevity {#sec2.8}
------------------------------------------------------------

Rapamycin reduces age-related intestinal pathologies in flies ([@bib17]). Given the increased lifespan upon gut-targeted FKH overexpression, we assessed the requirement for FKH for rapamycin-induced longevity. We knocked down *fkh* in the gut by RNAi with the *TiGS* driver. Treatment of uninduced flies with rapamycin significantly extended lifespan ([Figure 5](#fig5){ref-type="fig"}C; median survival + 11%, p = 1.79 × 10^−12^), and this extension was lost upon gut-specific RNAi against FKH ([Figure 5](#fig5){ref-type="fig"}C; p = 0.57), confirmed by CPH analysis ([Table S3](#mmc1){ref-type="supplementary-material"}; p = 6.66 × 10^−15^). Hence, FKH function in the gut is necessary for rapamycin-induced longevity.

Reduced IIS in the Gut Induced an FKH-Dependent Extension of Lifespan {#sec2.9}
---------------------------------------------------------------------

Downregulating IIS activity in progenitor cells of the gut extends *Drosophila* lifespan ([@bib8]). We examined the effect of a broader IIS reduction, and the contribution of FKH, by expressing *InR*^*DN*^ and RNAi against *fkh* under the control of the *TiGS* driver. The gut-targeted reduction of IIS resulted in a small, but significant, increase in lifespan ([Figure 5](#fig5){ref-type="fig"}D; median survival + 3%, p = 0.014), while RNAi against *fkh* resulted in slightly elevated early life mortality ([Figure 5](#fig5){ref-type="fig"}E; p = 0.077). Importantly, a reduction of IIS in the gut in combination with *fkh* knockdown failed to extend lifespan, and indeed it led to significantly short-lived flies ([Figure 5](#fig5){ref-type="fig"}E; p = 8.92 × 10^−7^). Hence, the decrease of IIS activity in the gut alone results in long-lived flies, and this not only requires FKH function but also is deleterious without it.

Reduced IIS Increases the Expression of Intestinal Transmembrane Transporters through FKH, and It Induces Enterocyte-Specific Nuclear Localization of FKH {#sec2.10}
---------------------------------------------------------------------------------------------------------------------------------------------------------

Our results indicate that FKH function in the gut is necessary for both rapamycin- and reduced IIS-induced longevity. Given the detrimental effect of FKH knockdown in guts with reduced IIS, in our subsequent analysis we focused on the identification of genes regulated by FKH in the gut upon downregulation of IIS. We isolated guts from flies with ubiquitous reduction of IIS with or without knockdown of FKH, and controls, and we carried out genome-wide transcript profiling using next-generation RNA sequencing.

We first identified the set of genes differentially expressed in wild-type and reduced-IIS guts (*daGS;UAS-InR*^*DN*^ *\> UAS-GFP RNAi* + RU486 versus *daGS;UAS-InR*^*DN*^ *\> UAS-GFP RNAi* − RU486) and the set of genes differentially expressed in reduced-IIS guts with or without RNAi against FKH (*daGS;UAS-InR*^*DN*^ *\> UAS-GFP RNAi* + RU486 versus *daGS;UAS-InR*^*DN*^ *\> UAS-fkh RNAi* + RU486). We reasoned that the transcriptional response regulated by FKH in response to reduced IIS should be indicated by genes whose expression levels are reverted back to wild-type levels upon FKH knockdown in reduced-IIS flies ([Figures 6](#fig6){ref-type="fig"}A and 6B). We carried out gene ontology (GO) category analysis on genes in the overlap between these two sets.Figure 6Reduced IIS in the Gut Results in a Transcriptional Response that Upregulates Transmembrane Transporters via FKH Function(A) In the adult gut, the overlap between the transcriptional response induced by reduced IIS compared to controls (*daGS;UAS-InR*^*DN*^*\> UAS-GFP RNAi* +RU486 versus *daGS;UAS-InR*^*DN*^*\> UAS- GFP RNAi* --RU486) and compared to flies with reduced IIS and *fkh* knockdown (*daGS;UAS-InR*^*DN*^*\> UAS-GFP RNAi* +RU486 versus *daGS;UAS-InR*^*DN*^*\> UAS-fkh RNAi* +RU486) revealed 31 upregulated and 43 downregulated genes.(B) Heatmap showing genes significantly upregulated or downregulated in both comparisons.(C) Significantly upregulated GO categories induced by reduced IIS in an FKH-dependent manner in the adult gut.

We found GO enrichment only among genes upregulated in reduced-IIS flies, particularly for genes encoding proteins involved in transmembrane transport ([Figure 6](#fig6){ref-type="fig"}C). Within this GO category were a number of genes responsible for the transport and uptake of nutrients, such as copper and zinc (*ctr1b* and *zip1*), glucose (*CG1208*), phospholipids (*mdr50*), and fatty acids (*pmp70*) ([Figure 6](#fig6){ref-type="fig"}B), suggesting that FKH could be increasing nutrient uptake and absorption in reduced-IIS flies.

*Drosophila* enterocytes (ECs) regulate nutrient transport and absorption in the midgut ([@bib31]). We next investigated whether reduced IIS affected subcellular FKH localization, and we found that it increased nuclear localization of FKH specifically in ECs, which are characterized by polyploidy and large nuclei ([Figure S6](#mmc1){ref-type="supplementary-material"}; t test, p \< 0.0001). In cells with smaller nuclei, possibly consisting of ISCs, EBs, and enteroendocrine cells (EEs), nuclear localization of FKH did not change ([Figure S6](#mmc1){ref-type="supplementary-material"}; t test, p = 0.78). Additionally, and in agreement with previously published work ([@bib8]), in the IIS mutant there were fewer cells with smaller nuclei, consistent with reduced ISC proliferation. These observations suggest a role for FKH in regulating transcription in ECs, including of genes related to nutrient transport and absorption, upon reduced IIS activity.

FKH Function Promotes Nutrient Absorption, and FKH Activity in Differentiated Gut Cells Results in Increased Longevity {#sec2.11}
----------------------------------------------------------------------------------------------------------------------

To confirm our transcriptomic data, we assessed by qRT-PCR the expression levels of transmembrane transporters, including *ctr1B*, *zip1*, *mdr50*, *pmp70*, and *CG1208* ([Figure S7](#mmc1){ref-type="supplementary-material"}A), and we found that they were increased in the IIS mutant (t test, p = 0. 0029, p = 0.0035, p = 0.031, p = 0.043, and p = 0.03, respectively; n = 3--4). RNAi against *fkh* abolished the differential expression of *ctr1B*, *mdr50*, *pmp70*, or *CG1208* (t test, p \> 0.05; n = 3--4), but *zip1* expression levels remained significantly increased (t test, p = 0.0085; n = 4). Linear model analysis showed a significant interaction between RU and genotype (p = 0.0004), showing that the expression of genes involved in transport of nutrients was increased in the IIS mutant in an FKH-dependent manner.

We next assessed the effect of gut-specific upregulation of FKH on the expression of nutrient transporters, and we found a significant increase in *ctr1B*, *zip1*, and *mdr50* expression in guts with the induction of *fkh* ([Figure S7](#mmc1){ref-type="supplementary-material"}B; t test, p = 0.02, p = 0.006, and p = 0.007, respectively). Therefore, FKH overexpression in the gut alone can upregulate expression of nutrient transporters.

To determine whether the upregulation of nutrient transporters also increased nutrient uptake, we assessed intestinal metal and lipid absorption. *Drosophila* metallothioneins are cysteine-rich proteins that bind heavy metals, such as zinc and copper, and their expression levels are used as a proxy measure of metal content of the *Drosophila* gut ([@bib5], [@bib42]). We assessed by qRT-PCR the expression levels of the *metallothioneinB* (*mtnB*) and *metallothioneinC* (*mtnC*) in guts isolated from flies with *fkh* knockdown alone or with reduced IIS with or without *fkh* knockdown. Reduced IIS increased expression of both metallothionein genes, and this increase was dependent on FKH ([Figure S7](#mmc1){ref-type="supplementary-material"}C), as confirmed by linear model analysis (interaction between RU and genotype, p = 0.0015). Next, we quantified *mtnB* and *mtnC* expression in guts with intestinal FKH overexpression and controls at 1 and 7 weeks of age. *mtnC* levels were significantly upregulated in *fkh*-overexpressing guts at both ages ([Figure S7](#mmc1){ref-type="supplementary-material"}D; t test, p = 0.02 and p = 0.005), whereas *mtnB* levels were significantly increased only at 7 weeks of age ([Figure S7](#mmc1){ref-type="supplementary-material"}D; t test, p = 0.01). These results indicate that FKH promotes intestinal metal uptake in the intestine upon reduced IIS activity.

Previous studies highlighted a key role for the fly gut in absorption and metabolism of dietary lipids ([@bib27], [@bib34]). The midgut displays an age-related decline in lipid storage, probably due to an overall reduction in intestinal lipid absorption, which results in increased starvation sensitivity ([@bib27]). We assessed intestinal lipid uptake with Nile Red staining to visualize lipid droplets in midguts with reduced IIS and with or without *fkh* knockdown. In agreement with previously published work, we detected lipid droplets in the anterior region of the midgut ([@bib27], [@bib34]), with a significant increase upon reduced IIS ([Figures 7](#fig7){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}E; t test, p = 0.0019). This was lost upon *fkh* knockdown specifically in the guts of reduced-IIS flies ([Figures 7](#fig7){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}E; t test, p = 0.094). These results suggest that FKH promotes intestinal lipid storage in response to reduced IIS. Gut-specific FKH overexpression also increased Nile Red staining in the midgut ([Figures 7](#fig7){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}F; t test, p = 2.29 × 10^−8^), TAG levels in whole flies ([Figure 7](#fig7){ref-type="fig"}C; t test, p = 0.033), and resistance to starvation in both young and old flies ([Figure 7](#fig7){ref-type="fig"}D; p = 0.0047 and p = 1.74 × 10^−5^).Figure 7FKH Promotes Intestinal Nutrient Uptake upon Overexpression and in Response to Reduced IIS, and FKH Activity in Differentiated Cells of the Gut Induces Longevity(A) Nile Red (red) and DAPI (blue) staining of the anterior region of midgut isolates from flies of genotypes *daGS \> UAS-InR*^*DN*^, *daGS;UAS-InR*^*DN*^*\> UAS-fkh RNAi*, and *daGS \> UAS-fkh RNAi* induced or not with 200 μM RU486. See also [Figure S7](#mmc1){ref-type="supplementary-material"}E.(B) Nile Red (red) and DAPI (blue) staining of the anterior region of midgut isolates from flies of genotype *TiGS \> UAS-fkh* induced or not with 200 μM RU486. See also [Figure S7](#mmc1){ref-type="supplementary-material"}F.(C) Quantification of whole-animal TAG levels normalized to total protein in flies of genotype *TiGS \< UAS-fkh* induced or not with RU486 revealed significant increases upon induction (t test, p = 0.033; n = 10; error bars represent SEM).(D) Starvation resistance of *TiGS \> UAS-fkh* females was significantly increased in the presence of RU486 at 1 week (p = 0.0047) and 10 weeks of age (p = 1.74 × 10^−5^).(E) Intestinal differentiated cell-specific overexpression of *UAS*-*fkh* under the control of *GS5966* driver extended lifespan (p = 2.03614 × 10^−7^). See also [Table S5](#mmc1){ref-type="supplementary-material"}.(F) Model. FKH integrates signals from AKT and TOR. dFOXO and FKH exert their pro-longevity effects in different tissues. In the gut, FKH improves barrier function and upregulates the expression of nutrient transporters, resulting in increased nutrient storage and resistance to starvation and overall contributing to increased longevity.

Our findings suggest a role for FKH in nutrient absorption. We next assessed whether increasing FKH activity specifically in differentiated gut cells, namely EEs and absorptive ECs, affected longevity. Upregulation of FKH in differentiated cells resulted in a significant increase in lifespan ([Figure 7](#fig7){ref-type="fig"}E; median survival +15%, p = 2.03 × 10^−7^). This finding further supports the transcriptomic and molecular analysis, and it pinpoints the pro-longevity effect of FKH to EEs and ECs.

*irs1* Knockout Upregulates *CG1208*, *pmp70*, and *zip1* Orthologs in Mouse Small Intestine {#sec2.12}
--------------------------------------------------------------------------------------------

Mouse small intestine is functionally and morphologically similar to *Drosophila* midgut, and it plays an essential role in the uptake of nutrients ([@bib43]). We therefore measured expression levels of orthologous nutrient transporters in duodenum from female mice with intestinal *Irs1* knockout (*VillCre::Irs1*^*lox/lox*^) and controls (*Irs1*^*lox/lox*^) at 3 months of age. We quantified mRNA levels of *Glut8*, *Abcd3*, *Slc39a3*, and *Slc31a1* (mouse orthologs of *CG1208*, *pmp70*, *zip1*, and *ctr1B*, respectively), and we found a significant increase in *Abcd3, Glut8*, and *Slc39a3* expression ([Figure S7](#mmc1){ref-type="supplementary-material"}G; t test, p = 0.006562, p = 0.029, and p = 0.019, respectively) upon intestinal *Irs1* knockout. Thus, consistent with our observations in the *Drosophila* gut, reduced IIS in mouse small intestine upregulates the expression of genes involved in nutrient transport.

Discussion {#sec3}
==========

The major role played by the IIS-and-TOR-signaling network during the control of metabolism, cell growth, and organismal aging has been under investigation for over two decades ([@bib1]). In *Drosophila*, dFOXO integrates signals from the insulin-PI3K-AKT branch of the IIS pathway ([@bib25]), and it has been considered to be the key TF mediating many of its transcriptional outputs and its effect on organismal lifespan ([@bib49]). Here we have shown that a second FOX family member, FKH, interacts with both the AKT and TOR branches to regulate organismal lifespan.

While the functionality of the phosphorylation events remains to be determined, based on our biochemical data, we propose a model in which FKH can be phosphorylated by AKT and TOR and integrate signals from them ([Figure 7](#fig7){ref-type="fig"}F). IIS activity leads to FKH phosphorylation, potentially contributing to a decrease in nuclear FKH. Insulin-dependent subcellular localization of FoxA2 in mammalian cells has been subject to conflicting reports. While [@bib60], [@bib61], reported complete nuclear exclusion of FoxA2, in vitro and in vivo in response to insulin, a study by [@bib65] showed that FoxA2 remained nuclear under all metabolic states in mouse hepatocytes. We did not detect complete nuclear FKH exclusion in the fly but a decrease in strong nuclear FKH staining upon in vitro and ex vivo insulin stimulation. Rapamycin feeding was previously shown to increase nuclear FKH in larvae ([@bib12], [@bib56]), lending further support to a regulating role of nutrient signaling in FKH subcellular localization in the fly.

We have established an important role for FKH in *Drosophila* longevity. Ubiquitous upregulation of FKH extends lifespan, and FKH is required for reduced IIS- and rapamycin-induced longevity. We found that FKH mediates starvation resistance of IIS mutants. Interestingly, *dfoxo* plays no role in either extension of lifespan by rapamycin or in the starvation resistance of *Drosophila* IIS mutants ([@bib49]). Furthermore, dFOXO is required for xenobiotic resistance of IIS mutants while FKH is not. These findings highlight different functional roles of dFOXO and FKH in determination of the phenotypes of IIS mutants and the response of lifespan to TORC1 inhibition. However, both TFs are necessary for reduced IIS-induced longevity, suggesting that they are functionally complementary. The identification of FKH as a TF downstream of both IIS and TOR branches enables a more insightful picture of the transcriptional regulation within the nutrient-signaling network, and it defies the notion that dFOXO is the key TF regulating *Drosophila* lifespan downstream of AKT kinase.

We found that the response of lifespan to DR in *Drosophila* is independent of FKH function, as has previously been shown for dFOXO ([@bib50]). In contrast, the *C. elegans* FoxA homolog PHA-4 is required for DR-induced longevity, but not reduced IIS-induced lifespan extension ([@bib36]). Hence, our results show a major evolutionarily functional divergence between PHA-4 and FKH, suggesting distinct mechanisms of organismal lifespan regulation by the worm and fly FoxA orthologs.

Here, we show that intestinal FKH upregulation is sufficient to extend lifespan, whereas gut-specific dFOXO overexpression does not ([@bib3]). The two TFs may, therefore, be modulating lifespan through different target genes in different tissues. We propose that tissue specificity might be the reason for the requirement of multiple TFs with lifespan-extending effects within the nutrient-signaling network, as is the case in worms ([@bib6], [@bib33]).

The *Drosophila* midgut is the functional equivalent of the mammalian stomach and small intestine, and similarly it contains distinct cell types with diverse functions ([@bib31]). ISCs and EBs are progenitor cells, whereas EEs and ECs are the sole two differentiated intestinal cell types. EEs primarily play a secretory role, while ECs are responsible for immune response, absorption of nutrients, and secretion of digestive enzymes. The interaction between IIS activity in *Drosophila* gut and aging has been intensively studied ([@bib3], [@bib8], [@bib45]). Major interest has focused on ISCs, and previous work showed that reduced IIS in progenitor cells decreases age-induced proliferation of ISCs and extends lifespan ([@bib8]). However, an exclusively deterministic role for ISCs during aging is contentious ([@bib39], [@bib46]). In addition to intestinal homeostasis and stem cell maintenance, other aspects of gut physiology, such as immunity, secretion, and absorption, are also likely to influence organismal aging.

We found that a broader intestinal reduction of IIS activity with *TiGS* driver also results in lifespan extension but becomes detrimental upon gut-specific FKH knockdown. Despite increased longevity upon broad intestinal upregulation of FKH, restricting its overexpression to intestinal progenitor cells does not affect lifespan. Increasing FKH activity specifically in differentiated cells significantly increases longevity, suggesting this pro-longevity effect is ISC independent. Concordantly, FKH-overexpressing guts display improved barrier function without any changes in age-related ISC proliferation.

Induction of FKH activity by either lowered IIS or direct overexpression induced the expression of nutrient transporters. Aging results in decreased intestinal lipid storage and whole-body nutrient stores ([@bib27], [@bib45]), which correlates with age-related repression of lipases essential for lipid absorption ([@bib27]). Reduced intestinal storage may be due to an overall decline in absorptive capacity, resulting in decreased whole-body metabolic stores. We propose a model whereby FKH-dependent expression of nutrient transporters overcomes this decline and contributes to starvation resistance and longevity ([Figure 7](#fig7){ref-type="fig"}F). Concordantly, we show that starvation resistance declines over aging, likely due to increasingly poor nutrient uptake, but it can be enhanced by intestinal FKH induction at both young and old age. Similarly, upon reduced IIS, FKH activity may promote nutrient uptake, leading to better nutrient stores, contributing to increased starvation resistance. Recent work ([@bib34]) revealed increased midgut lipid storage and expression of nutrient transporters in *Drosophila* ECs in response to DR. It is possible that upregulation of nutrient transporters is promoted by a number of lifespan-extending interventions. Intestinal barrier function is another important aspect of gut physiology improved by FKH, also likely to be contributing to its pro-longevity effects. Absorptive and barrier capacity of gut epithelial cells may well be functionally linked and also reflective of an overall improvement in the maintenance of EC physiology over age. Altogether, our data suggest that the pro-longevity effect of FKH in the gut involves ISC-independent mechanisms.

Finally, *irs1* knockout led to the upregulation of three orthologous nutrient transporters in the mouse small intestine. This suggests that an evolutionarily conserved mechanism, by which the reduction of IIS upregulates intestinal nutrient absorption, is also present in mammals. Intriguingly, mammalian FoxAs provide protection against hypoglycemia ([@bib18]). We propose that fly and mammalian FoxAs might show functional convergence in promoting nutrient uptake. Further studies are required to dissect out detailed consequences of the upregulation of nutrient transporters on digestive and absorptive capacity of the fly and mammalian gut over aging. In humans, aging causes a decrease in nutrient absorption, and malnourishment is a major problem for many elderly people ([@bib62]). Our findings may, therefore, represent new directions for therapeutic interventions to improve human health during aging.

Experimental Procedures {#sec4}
=======================

Fly Husbandry {#sec4.1}
-------------

Stocks were maintained and experiments conducted at 25°C on a 12-hr light/dark cycle at 60% humidity, on food containing 10% (w/v) brewer's yeast, 5% (w/v) sucrose, and 1.5% (w/v) agar, unless otherwise noted. Please see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further details.

Statistical Analysis {#sec4.2}
--------------------

Statistical analyses were performed in JMP (version 9) software (SAS Institute), R, or Excel (Microsoft). Survival data were analyzed with either log rank test or CPH using Excel (Microsoft) or R using the survival package (Terry Therneau, <https://cran.r-project.org/web/packages/survival/index.html>). qPCR analysis was performed by using either Student's t test or a linear model.

Mouse Models and Husbandry {#sec4.3}
--------------------------

All mice were maintained at 22°C under a 12-hr light/dark cycle (lights on from 6:00 a.m. to 6:00 p.m.). Mice were housed in groups of three to five same-sex littermates under specific pathogen-free conditions within individually ventilated cages (Techniplast UK, Kettering, Northamptonshire, UK). Mice had ad libitum access to normal chow (ssniff R/M-H phytoestrogen-poor \[9% fat, 34% protein, and 57% carbohydrate\], ssniff Spezialdiäten, Soest, Germany) and water. Female mice were sacrificed at 3 months. Duodenums were dissected and tissues were snap-frozen in liquid nitrogen. Details of the generation of tissue-specific *Irs1* knockout (KO) mouse are described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Ethics Statement {#sec4.4}
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